Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Twist Bioscience Corporation · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Sep 2030 | $795.05M | $781.79M - $802.65M | -$542.77M | $1.33 | 3 |
| Sep 2029 | $687.20M | $675.74M - $693.77M | -$469.14M | $0.36 | 4 |
| Sep 2028 | $599.53M | $597.67M - $601.39M | -$409.30M | -$0.982 | 6 |
| Sep 2027 | $519.51M | $510.92M - $528.10M | -$354.66M | -$1.374 | 6 |
| Sep 2026 | $446.61M | $446.46M - $446.76M | -$304.89M | -$2.054 | 5 |
| Sep 2025 | $374.81M | $374.05M - $375.34M | -$255.88M | -$1.313 | 5 |
| Sep 2024 | $310.91M | $310.12M - $311.41M | -$212.26M | -$3.717 | 7 |
| Sep 2023 | $277.49M | $274.37M - $280.02M | -$189.44M | -$3.347 | 6 |
| Sep 2022 | $202.91M | $200.54M - $204.86M | -$209.80M | -$4.394 | 4 |
| Sep 2021 | $130.95M | $129.42M - $132.21M | -$163.32M | -$3.136 | 5 |
| Sep 2020 | $80.88M | $79.94M - $81.66M | -$79.23M | -$3.546 | 5 |
| Sep 2019 | $52.81M | $52.19M - $53.32M | -$36.05M | -$3.778 | 4 |